Trial intelligence / Profile preview

AV7909 Drug-Vaccine Interaction Study with Ciprofloxacin or Doxycycline

NCT04067011Phase 2Completed

Sponsor
Emergent BioSolutions
Start
Aug 2019
Primary completion
Mar 2020
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of anthrax vaccine adsorbed in anthrax, sponsored by Emergent BioSolutions. Started Aug 2019; status: completed.

02

Drugs

anthrax vaccine adsorbed
03

Conditions

anthrax

Beyond the preview

Go deeper on NCT04067011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04067011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call